Australia's Resonance Health Ltd. named Alison Laws CEO, effective Feb. 23.
Laws joined the healthcare analysis company as a research consultant in 2016, and subsequently served as global account manager.
Resonance Health appoints CEO
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Australia's Resonance Health Ltd. named Alison Laws CEO, effective Feb. 23.
Laws joined the healthcare analysis company as a research consultant in 2016, and subsequently served as global account manager.